SEC Comment Letter for Sunshine Biopharma Inc. (SBFM, SBFMW) (CIK 0001402328) (SBFM) — Jul 2, 2010

Sunshine Biopharma Inc. (SBFM, SBFMW) (CIK 0001402328)
Date: July 2, 2010 · CIK: 0001402328 · Accession: 0000000000-10-037485

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-52898

Date

July 2, 2010

Author

Karen J. Garnett

Form

UPLOAD

Company

Sunshine Biopharma Inc. (SBFM, SBFMW) (CIK 0001402328)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549-7010 DIVISION OF CORPORATION FINANCE July 2, 2010 Dr. Steve N. Slilaty Chief Executive Officer Sunshine Biopharma, Inc. 6100 Royalmount Avenue Montreal, Quebec, Canada H4P 2R2

Re: Sunshine Biopharma, Inc. Schedule 14C Filed April 21, 2010 File No. 000-52898

Dear Dr. Slilaty:

We have completed our review of your filings and do not have any further comments at this time.

Sincerely,
Karen J. Garnett
Assistant Director

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-7010

       DIVISION OF
CORPORATION FINANCE

     July 2, 2010

Dr. Steve N. Slilaty Chief Executive Officer Sunshine Biopharma, Inc. 6100 Royalmount Avenue Montreal, Quebec, Canada H4P 2R2

Re: Sunshine Biopharma, Inc.
 Schedule 14C
Filed April 21, 2010
 File No. 000-52898

Dear Dr. Slilaty:

We have completed our review of your filings and do not have any further
comments at this time.

Sincerely,
    Karen J. Garnett
Assistant Director

SecProbe.io